Fiveable

💊Pharmacology for Nurses Unit 30 Review

QR code for Pharmacology for Nurses practice questions

30.3 Laxatives and Stool Softeners

30.3 Laxatives and Stool Softeners

Written by the Fiveable Content Team • Last updated August 2025
Written by the Fiveable Content Team • Last updated August 2025
💊Pharmacology for Nurses
Unit & Topic Study Guides

Types and Mechanisms of Laxatives and Stool Softeners

Laxatives and stool softeners help manage constipation, but they do so through very different mechanisms. Picking the right one depends on the cause of constipation, how quickly relief is needed, and the patient's overall health. Knowing these categories well will help you make safe clinical decisions.

Bulk-Forming Laxatives

Bulk-forming laxatives are the most physiologically natural option. They contain soluble fiber that absorbs water in the intestines, forming a gel-like mass. This increases fecal bulk, which stretches the intestinal wall and stimulates peristalsis.

  • Examples: psyllium (Metamucil), methylcellulose (Citrucel), polycarbophil (FiberCon)
  • Indications: chronic constipation, irritable bowel syndrome, diverticular disease. These are first-line for patients who need long-term bowel regulation and want to avoid straining.
  • Onset: typically 12–72 hours, so these are not appropriate when rapid relief is needed
  • Side effects: bloating, flatulence, and abdominal discomfort from bacterial fermentation of the fiber. These effects often improve after the first few days of use.

Must remember: Bulk-forming laxatives require adequate fluid intake to work. Without enough water, they can actually worsen constipation or cause intestinal obstruction.

Osmotic Laxatives

Osmotic laxatives contain poorly absorbed substances that create an osmotic gradient, pulling water into the intestinal lumen. This softens the stool and increases intestinal pressure, which stimulates motility.

  • Examples: magnesium hydroxide (Milk of Magnesia), polyethylene glycol (MiraLAX), lactulose (Kristalose)
  • Indications: acute and chronic constipation, bowel preparation before colonoscopy. Polyethylene glycol solutions (GoLYTELY) are commonly used for pre-procedure bowel cleansing.
  • Onset: varies by agent. Magnesium hydroxide works in 30 minutes to 6 hours; polyethylene glycol typically takes 1–3 days.
  • Side effects: electrolyte imbalances (particularly hypermagnesemia with magnesium-based products in patients with renal impairment), dehydration, and abdominal cramping from excessive fluid shifts.
Laxatives and stool softeners, Frontiers | Action Mode of Gut Motility, Fluid and Electrolyte Transport in Chronic Constipation

Stimulant Laxatives

Stimulant laxatives act directly on the intestinal wall. They stimulate the myenteric plexus (the nerve network that controls gut motility) and promote secretion of water and electrolytes into the intestinal lumen while reducing water reabsorption.

  • Examples: bisacodyl (Dulcolax), senna (Senokot), castor oil
  • Indications: acute constipation, opioid-induced constipation, bowel preparation before surgery. These provide the most rapid and predictable results among oral laxatives.
  • Onset: oral forms work in 6–12 hours; rectal bisacodyl works in 15–60 minutes
  • Side effects: abdominal cramping, diarrhea, electrolyte imbalances. Long-term use can cause melanosis coli (a brownish-black discoloration of the colon mucosa) and may lead to laxative dependence where the bowel loses its natural ability to contract.

Clinical pearl: Stimulant laxatives are meant for short-term use. If a patient needs them regularly, that signals a need to investigate the underlying cause of constipation.

Emollient Laxatives (Stool Softeners)

Stool softeners work differently from true laxatives. They are surfactants that lower the surface tension of the stool, allowing water and fats to penetrate it more easily. They don't stimulate peristalsis directly.

  • Example: docusate sodium (Colace)
  • Indications: prevention of constipation (rather than treatment of existing constipation), hemorrhoids, anal fissures, post-surgical patients. The goal is to reduce straining.
  • Onset: 1–3 days. These are preventive, not fast-acting.
  • Side effects: mild abdominal cramping and diarrhea; electrolyte imbalances are rare and typically only occur with excessive use.

Stool softeners are often prescribed prophylactically for patients on opioids or those who should avoid straining (post-cardiac surgery, postpartum). They work best when combined with adequate hydration.

Laxatives and stool softeners, Frontiers | Pharmacological Therapies and Their Clinical Targets in Irritable Bowel Syndrome ...

Nursing Considerations and Patient Education

Nursing Considerations

Before administering any laxative or stool softener, a thorough assessment sets the foundation for safe care:

  1. Assess bowel history and risk factors. Ask about the patient's normal bowel pattern, last bowel movement, dietary habits, and fluid intake. Review the medical history for contraindications such as bowel obstruction, fecal impaction, or inflammatory bowel disease.
  2. Review the medication list. Many drugs cause constipation, especially opioids, anticholinergics, iron supplements, and calcium channel blockers. Identifying these helps determine whether the constipation is drug-induced.
  3. Choose the right agent. Match the laxative type to the clinical situation. A post-surgical patient who needs to avoid straining benefits from docusate, while a patient with acute constipation may need a stimulant laxative.
  4. Monitor fluid and electrolyte balance. This is especially critical with osmotic and stimulant laxatives. Watch for signs of dehydration (decreased urine output, dry mucous membranes) and electrolyte disturbances (muscle weakness, cardiac irregularities).
  5. Ensure adequate fluid intake. Encourage 8–10 glasses of water per day. This is essential for all laxative types but particularly for bulk-forming agents.
  6. Provide comfort measures. Ensure privacy and easy bathroom access. Timing laxative administration so the expected effect occurs during waking hours improves patient comfort.
  7. Monitor for adverse effects. Report severe abdominal pain, bloody stools, or persistent diarrhea to the provider promptly, as these may indicate a complication or need for therapy adjustment.

Patient Education

Effective patient teaching goes beyond "take this pill." Patients need to understand why they're taking the medication and how to support it with lifestyle changes.

Medication-specific teaching:

  • Explain what the prescribed laxative does and how long it takes to work. Patients who expect immediate results from a bulk-forming agent will think it's not working and may take extra doses.
  • Review dosage, frequency, and whether the medication is for short-term or ongoing use.
  • Caution specifically against long-term stimulant laxative use without medical supervision, as this can lead to dependence and worsening constipation over time.

When to contact the provider:

  • No bowel movement for 3 or more days despite laxative use
  • Severe abdominal pain or distension
  • Blood in the stool
  • Signs of dehydration (dizziness, dark urine, excessive thirst)

Lifestyle modifications to reinforce:

  • Hydration: Drink plenty of water and clear fluids throughout the day.
  • Dietary fiber: Incorporate whole grains, legumes, fruits (prunes and apples are particularly effective), and vegetables (broccoli, carrots) into daily meals. Increase fiber gradually to minimize bloating.
  • Physical activity: Regular movement such as walking or yoga stimulates intestinal motility.
  • Bowel routine: Encourage going to the bathroom at the same time each day, ideally after a meal, to take advantage of the natural gastrocolic reflex.
  • Non-pharmacological options: Fiber supplementation (bran, psyllium) and gentle abdominal massage using circular motions can complement medication therapy.